Binghua O. Dai
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Nuclear receptors-mediated lipid metabolism dysregulation: A potential mechanism linking PFOA/PFOS to hepatocellular carcinoma.
Journal: Ecotoxicology and environmental safety
Published: July 21, 2025
APOA2 mediates immune therapy tolerance in hepatocellular carcinoma by inhibiting the antigen-presenting function of dendritic cells through the PPAR signaling pathway.
Journal: Translational cancer research
Published: February 10, 2025
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study.
Journal: Frontiers in immunology
Published: July 12, 2024
Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer.
Journal: Cancer reports (Hoboken, N.J.)
Published: November 10, 2023
Expression pattern of PD-1/PD-L1 in primary liver cancer with clinical correlation.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 06, 2023
Response to letter entitled: Re: 'Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial'.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 23, 2022
The surgical outcomes and risk factors of giant hepatic haemangiomas: a single centre experience.
Journal: BMC surgery
Published: May 03, 2022
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 05, 2021
Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 06, 2020
Long Non-Coding RNA SNHG14 Contributes to the Development of Hepatocellular Carcinoma via Sponging miR-217.
Journal: OncoTargets and therapy
Published: June 26, 2020
Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients.
Journal: Neoplasia (New York, N.Y.)
Published: June 24, 2020
Last Updated: 09/26/2026